Retatrutide stall timeline Retatrutide is the newest entrant, a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously
The recommended baseline panel for menopausal women considering weight loss peptides includes: fasting glucose and HbA1c (metabolic baseline), fasting insulin (insulin resistance assessment), lipid panel including triglycerides (cardiovascular risk), complete metabolic panel (liver and kidney function), IGF-1 (baseline for GH secretagogue monitoring), thyroid panel including TSH and free T4, estradiol and FSH (menopausal status confirmation), and DEXA scan if available (body composition baseline)
When vomiting, confusion, or rapid breathing are present, emergency assessment matters because dehydration and acid buildup can worsen quickly
If youve had side effects from a weight loss injection, even if youve recovered, you can report them to the UKs Yellow Card scheme
Switching is common and can be smooth with the right plan
Its a misfired routine or a treatable condition like circadian rhythm disorder or delayed sleep phase syndrome